London man among thousands who've rolled up their sleeves to trial Lyme disease vaccine

The clinical trial for the potential vaccine, VLA15, began in August 2022. Stage 3 trials got underway in late 2023, involving more than 9,000 participants from areas of Canada, Europe, and the U.S. where the disease is endemic.

The clinical trial for the potential vaccine, VLA15, began in August 2022. Stage 3 trials got underway in late 2023, involving more than 9,000 participants from areas of Canada, Europe, and the U.S. where the disease is endemic.

The clinical trial for the potential vaccine, VLA15, began in August 2022. Stage 3 trials got underway in late 2023, involving more than 9,000 participants from areas of Canada, Europe, and the U.S. where the disease is endemic.

News/Canada/London